Navigation Links
Global Pharma Integrates Imperium(TM) to Support Launch Content ROI Initiatives!
Date:10/13/2008

Modevity's Imperium(TM) Market Leading Content Rights Management System Supports Global Pharma Client in Closing the Loop on Their Content Spend

WEST CHESTER, Pa., Oct. 13 /PRNewswire/ -- Modevity, LLC announced today that a leading global pharmaceutical manufacturer has integrated Modevity's Imperium technology to become the primary platform for the secure distribution, data collection, viewer tracking and reporting analytics for their new product video content. Imperium is applied to this new medical educational and promotional content which is then provided to targeted physicians using multiple distribution methodologies. Imperium tracks all content viewing activities and collects physician provided information both pre- and post-view. All data is then made available through the Imperium Management Console for reporting and analytics.

Modevity's Imperium(TM) product is a state-of-the-art content rights management system that offers life sciences companies a flexible platform for the secure distribution, content management, custom data collection, viewer tracking and reporting analytics for their digital content utilizing any distribution methodology including Streaming, CD/DVD, Flash Drive, or even eMail attachment.

Today's pharmaceutical organizations are regularly presented with market and technology challenges and opportunities. From advanced physician portals, social networking tools to streaming video, closed loop strategies and now content rights management technologies.

"The Imperium product utilizes our proprietary encryption and licensing server technology to secure, manage, track and report on our client's digital content," stated Tom J. Canova, Co-Founder/CMO Modevity. Mr. Canova adds, "Imperium can become a powerful technology solution to support any Pharma's Closed Loop Marketing and Medical Education program initiatives."

"Organizations are becoming more dependent on virtual communications technologies such
'/>"/>

SOURCE Modevity, LLC
Copyright©2008 PR Newswire.
All rights reserved

Page: 1 2

Related medicine news :

1. Elements for a UN Global Framework on Mercury Agreed to
2. Intellect Neurosciences, Inc. Grants to Top Tier Global Pharmaceutical Company an Option to License Certain Alzheimers Patents and Patent Applications
3. Catholic Health Organizations Launch Ministry-Wide Effort to Raise Awareness About Global Climate Change
4. Global Sourcing Strategies for the Pharmaceutical Industry 10th - 11th November, Marriott Princeton, New Jersey USA
5. Alzheimers Foundation of America Encourages Global Action on Awareness Raising
6. Dreamhealer Encourages Global Healing of Those Affected by Disasters or Illness
7. Underwriters Laboratories to Host Global Leadership Conference on Fire and Life Safety
8. Does probiotic intervention induce the serum global lipid profile change?
9. Lumension Security Receives Frost & Sullivan 2008 Global Market Penetration Leadership Award
10. Perrigo Company To Present at the Merrill Lynch Global Pharmaceutical Conference
11. Harvard University recipient of Global Health Nutrition grant
Post Your Comments:
*Name:
*Comment:
*Email:
Breaking Medicine Technology:Phase III Study Demonstrates INVEGA(R) SUSTENNA(TM) (paliperidone palmitate) Statistically Similar to RISPERDAL(R) CONSTA(R) (risperidone) Long-Acting Injection 2Phase III Study Demonstrates INVEGA(R) SUSTENNA(TM) (paliperidone palmitate) Statistically Similar to RISPERDAL(R) CONSTA(R) (risperidone) Long-Acting Injection 3Phase III Study Demonstrates INVEGA(R) SUSTENNA(TM) (paliperidone palmitate) Statistically Similar to RISPERDAL(R) CONSTA(R) (risperidone) Long-Acting Injection 4Phase III Study Demonstrates INVEGA(R) SUSTENNA(TM) (paliperidone palmitate) Statistically Similar to RISPERDAL(R) CONSTA(R) (risperidone) Long-Acting Injection 5Phase III Study Demonstrates INVEGA(R) SUSTENNA(TM) (paliperidone palmitate) Statistically Similar to RISPERDAL(R) CONSTA(R) (risperidone) Long-Acting Injection 6Phase III Study Demonstrates INVEGA(R) SUSTENNA(TM) (paliperidone palmitate) Statistically Similar to RISPERDAL(R) CONSTA(R) (risperidone) Long-Acting Injection 7Phase III Study Demonstrates INVEGA(R) SUSTENNA(TM) (paliperidone palmitate) Statistically Similar to RISPERDAL(R) CONSTA(R) (risperidone) Long-Acting Injection 8Phase III Study Demonstrates INVEGA(R) SUSTENNA(TM) (paliperidone palmitate) Statistically Similar to RISPERDAL(R) CONSTA(R) (risperidone) Long-Acting Injection 9Phase III Study Demonstrates INVEGA(R) SUSTENNA(TM) (paliperidone palmitate) Statistically Similar to RISPERDAL(R) CONSTA(R) (risperidone) Long-Acting Injection 10Peregrine Pharmaceuticals Reports Financial Results for the Second Quarter of Fiscal Year 2010 2Peregrine Pharmaceuticals Reports Financial Results for the Second Quarter of Fiscal Year 2010 3Peregrine Pharmaceuticals Reports Financial Results for the Second Quarter of Fiscal Year 2010 4Peregrine Pharmaceuticals Reports Financial Results for the Second Quarter of Fiscal Year 2010 5Peregrine Pharmaceuticals Reports Financial Results for the Second Quarter of Fiscal Year 2010 6Peregrine Pharmaceuticals Reports Financial Results for the Second Quarter of Fiscal Year 2010 7Peregrine Pharmaceuticals Reports Financial Results for the Second Quarter of Fiscal Year 2010 8Peregrine Pharmaceuticals Reports Financial Results for the Second Quarter of Fiscal Year 2010 9Peregrine Pharmaceuticals Reports Financial Results for the Second Quarter of Fiscal Year 2010 10Peregrine Pharmaceuticals Reports Financial Results for the Second Quarter of Fiscal Year 2010 11Peregrine Pharmaceuticals Reports Financial Results for the Second Quarter of Fiscal Year 2010 12Peregrine Pharmaceuticals Reports Financial Results for the Second Quarter of Fiscal Year 2010 13Peregrine Pharmaceuticals Reports Financial Results for the Second Quarter of Fiscal Year 2010 14Prototype 7 foot tall sanitizer automates disinfection of hard to clean hospital equipment 53346 1Prototype 7 foot tall sanitizer automates disinfection of hard to clean hospital equipment 53346 2National assessment done on potential invasive snail and slug pests in US 9440 1Iron isotopes as a tool in oceanography 9436 1Iron isotopes as a tool in oceanography 9436 2Iron isotopes as a tool in oceanography 9436 3